Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biochemical Systems International is an Italian diagnostics and medical device company focused on rapid diagnostics, telemedicine, and clinical chemistry analysis. The company develops, manufactures, and markets point-of-care and self-testing systems, with a particular emphasis on metabolic syndrome monitoring, including blood glucose and multiparameter lipid testing. Its product portfolio includes blood glucose monitoring systems, multiparametric readers, disposable reagent-strip based tests, and diabetes management offerings such as continuous glucose monitoring and insulin pump solutions. The company states that it carries out in-house R&D, manufacturing, quality control, and technical support in Italy, and highlights internal production of reagent strips. Biochemical Systems International serves laboratories, pharmacies, physicians, hospitals, and home-use settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biochemical Systems International.